(Q50971154)

26 March 2018

title

Peripheral vasoactivity in familial hypercholesterolemic subjects treated with heparin-induced extracorporeal LDL precipitation (HELP). (English)

1 reference

26 March 2018

0 references

Stadler RW

1

1 reference

26 March 2018

Ibrahim SF

series ordinal

2

1 reference

26 March 2018

Lees RS

series ordinal

3

1 reference

26 March 2018

publication date

1 February 1997

1 reference

26 March 2018

published in

Atherosclerosis

1 reference

26 March 2018

volume

128

1 reference

26 March 2018

issue

2

1 reference

26 March 2018

page(s)

241-249

1 reference

26 March 2018

Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Removal of low-density lipoproteins (LDL) and fibrinogen by precipitation with heparin at low pH: clinical application and experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. HEL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Regression of carotid plaques during low density lipoprotein cholesterol elimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Low-density lipoprotein plasmaphaeresis with and without lovastatin in the treatment of the homozygous form of familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Enhanced constriction of the peripheral large artery in response to acute induction of a low-flow state in human hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

New methods for arterial diameter measurement from B-mode images.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Non-invasive detection of early endothelial dysfunction in hypercholesterolaemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Response of digital arteries to endothelium dependent and independent vasodilators in patients with Raynaud's phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905998-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(96)05998-9

1 reference

26 March 2018

1 reference

26 March 2018